Literature DB >> 10725903

Is there immunity to Schistosoma japonicum?

A G Ross1, A C Sleigh, Y S Li, G M Williams, G D Aligui, D P McManus.   

Abstract

The Oriental schistosome, Schistosoma japonicum, unlike the other two major schistosomes that infect humans (S. mansoni and S. haematobium), is a zoonotic species. The transmission dynamics and the potential effects of host-related regulatory factors, including immunity, are likely to be distinct for this parasite. Here, Allen Ross and collaborators from Australia, China and the Philippines discuss recently published and established epidemiological and laboratory data bearing on anti-infection immunity to Asian schistosomiasis, and contrast these findings with the emerging picture of development of anti-infection immunity against the African schistosomes. Implications for vaccines and other control strategies for schistosomiasis japonica are also discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725903     DOI: 10.1016/s0169-4758(99)01621-x

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  8 in total

1.  Familial aggregation of human infection with Schistosoma japonicum in the Poyang Lake region, China.

Authors:  Magda K Ellis; Yuesheng Li; Zhu Rong; Honggen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2005-10-13       Impact factor: 3.981

Review 2.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Carboxylic acids as biomarkers of Biomphalaria alexandrina snails infected with Schistosoma mansoni.

Authors:  Salwa M F Abou Elseoud; Nashwa S Abdel Fattah; Hayam M Ezz El Din; Hala Abdel Al; Hanan Mossalem; Noha Elleboudy
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

4.  Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum.

Authors:  R Zhang; A Yoshida; T Kumagai; H Kawaguchi; H Maruyama; T Suzuki; M Itoh; M El-Malky; N Ohta
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest China.

Authors:  Elizabeth J Carlton; Michelle Hsiang; Yi Zhang; Sarah Johnson; Alan Hubbard; Robert C Spear
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

6.  Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.

Authors:  Mario Jiz; Jennifer F Friedman; Tjalling Leenstra; Blanca Jarilla; Archie Pablo; Gretchen Langdon; Sunthorn Pond-Tor; Hai-Wei Wu; Daria Manalo; Remigio Olveda; Luz Acosta; Jonathan D Kurtis
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

7.  Evaluation of mammalian and intermediate host surveillance methods for detecting schistosomiasis reemergence in southwest China.

Authors:  Elizabeth J Carlton; Michael N Bates; Bo Zhong; Edmund Y W Seto; Robert C Spear
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

8.  Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?

Authors:  Elizabeth J Carlton; Alan Hubbard; Shuo Wang; Robert C Spear
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.